Search results
3 Gene Editing Stocks With the Best Long-Term Potential
InvestorPlace via Yahoo Finance· 1 year agoGene editing stocks present themselves as one of the more lucrative investments in the healthcare...
Obesity fighting success fuels Novo bet on gene-editing tech
Reuters via Yahoo News· 1 year agoCapitalising on strong demand for its obesity therapies, Novo Nordisk's growing appetite for deals...
Is CRISPR Therapeutics the Best Gene-Editing Stock?
Motley Fool· 7 months agoA striking analogy can be drawn between the development of monoclonal antibodies and the emergence of CRISPR-based gene editing. Since the first Food and...
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Motley Fool· 6 months agoThe pace of innovation in biotechnology is accelerating at a rapid clip. It took researchers 13...
The gene-editing technology in your store-bought tomatoes that could eat agriculture
Fortune via Yahoo Finance· 1 year agoThe small tomatoes on shelves of supermarkets in Japan may look like normal fruit, but they are...
7 Moonshot Investments Upending a $10 Trillion Industry
InvestorPlace via Yahoo Finance· 2 years agoThis article is excerpted from Tom Yeung’s Profit & Protection newsletter. To make sure you don’t...
IBD Stock Of The Day Vertex Pharma: Why Its 'Sandbox' Approach Is Unusual In Biotech
Investor's Business Daily· 2 years agoVertex Pharmaceuticals is the IBD Stock Of The Day as VRTX stock climbs higher on expectations for...
Play US Gene Treatment Approval in SBIO
ETF Trends via Yahoo Finance· 6 months agoTech has been a big driver of market resilience this year, with AI specifically boosting earnings for all kinds of companies. That said, technology isn’t...
The Zacks Analyst Blog Highlights ARK Innovation ETF, Roundhill Cannabis ETF, Kelly CRISPR & Gene...
Zacks via Yahoo Finance· 6 months agoARK Innovation ETF, Roundhill Cannabis ETF, Kelly CRISPR & Gene Editing Technology ETF, Invesco...
Startup Uses AI to Edit Human DNA
Futurism via Yahoo News· 2 months agoA team of resaerchers at a Berkeley-based startup called Profulent claim to have used generative AI technologies to edit human DNA. As the New York Times...
